Welcome!

Machine Learning Authors: Corey Roth, Yeshim Deniz, Pat Romanski, Elizabeth White, Liz McMillan

News Feed Item

Truven Health Analytics Introduces Role-Based Micromedex® Solution for Pharmaceutical Companies

Truven Health AnalyticsTM today announced the global availability of its new Micromedex® Pharmaceutical Knowledge solution, specifically designed to meet the needs of professionals in the pharmaceutical and associated business sectors.

Forty-four of the top 50 pharmaceutical companies around the world rely on Micromedex Solutions for trusted, global drug evidence. The new Micromedex Pharmaceutical Knowledge solution offers a unique, role-based interface for advanced searching across multiple databases, drug results customization and data export, to better support research efficiencies in the pharmaceutical (non-hospital) business setting.

“By partnering closely with our customers at every stage in the development of this solution, we’re confident our goal of creating a tailored, more productive pharmaceutical user experience has been achieved,” said Thomas Hegelund, Senior Vice President and General Manager with Truven Health Analytics. “The new Pharmaceutical Knowledge solution brings together the trusted evidence and global guidance of Micromedex clinical content with specific functionality our pharmaceutical customers’ business demands.”

Truven Health Analytics is providing dedicated trainers with pharmaceutical sector experience, tailored promotional support and user engagement programs to help raise organizational adoption and ensure customers receive the most value from the solution experience.

About Truven Health Analytics

At Truven Health Analytics, we’re dedicated to delivering the answers our clients need to improve healthcare quality and access, and reduce costs. Our unmatched data assets, technology, analytic expertise, and comprehensive perspective have served the healthcare industry for more than 30 years. Everyday our insights and solutions give hospitals and clinicians, employers and health plans, state and federal government, life sciences researchers, and policymakers the confidence they need to make the right decisions, right now, every time.

Truven Health Analytics owns some of the most trusted brands in healthcare, such as Micromedex, ActionOI, 100 Top Hospitals, MarketScan, and Advantage Suite. Truven Health has its principal offices in Ann Arbor, Mich.; Chicago; and Denver. For more information, please visit www.truvenhealth.com.

About Micromedex® Pharmaceutical Knowledge

Micromedex Pharmaceutical Knowledge is a unique, role-based solution providing trusted evidence and global guidance with a pharmaceutical perspective. With the specific needs of pharmaceutical and associated industry users in mind, this new solution is enhanced for advanced searching, drug results comparison, and aggregation with other information resources. A single, consolidated search across multiple resources - DRUGDEX®, Martindale and Index Nominum – delivers fast, accurate results to pharmaceutical users, in a way that complements their workflow. For more information, please visit www.micromedex.com/pharmaceutical.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

CloudEXPO Stories
The deluge of IoT sensor data collected from connected devices and the powerful AI required to make that data actionable are giving rise to a hybrid ecosystem in which cloud, on-prem and edge processes become interweaved. Attendees will learn how emerging composable infrastructure solutions deliver the adaptive architecture needed to manage this new data reality. Machine learning algorithms can better anticipate data storms and automate resources to support surges, including fully scalable GPU-centric compute for the most data-intensive applications. Hyperconverged systems already in place can be revitalized with vendor-agnostic, PCIe-deployed, disaggregated approach to composable, maximizing the value of previous investments.
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. End users now struggle to navigate multiple environments with varying degrees of performance. Companies are unclear on the security of their data and network access. And IT squads are overwhelmed trying to monitor and manage it all.
Machine learning provides predictive models which a business can apply in countless ways to better understand its customers and operations. Since machine learning was first developed with flat, tabular data in mind, it is still not widely understood: when does it make sense to use graph databases and machine learning in combination? This talk tackles the question from two ends: classifying predictive analytics methods and assessing graph database attributes. It also examines the ongoing lifecycle for machine learning in production. From this analysis it builds a framework for seeing where machine learning on a graph can be advantageous.'
With more than 30 Kubernetes solutions in the marketplace, it's tempting to think Kubernetes and the vendor ecosystem has solved the problem of operationalizing containers at scale or of automatically managing the elasticity of the underlying infrastructure that these solutions need to be truly scalable. Far from it. There are at least six major pain points that companies experience when they try to deploy and run Kubernetes in their complex environments. In this presentation, the speaker will detail these pain points and explain how cloud can address them.
When applications are hosted on servers, they produce immense quantities of logging data. Quality engineers should verify that apps are producing log data that is existent, correct, consumable, and complete. Otherwise, apps in production are not easily monitored, have issues that are difficult to detect, and cannot be corrected quickly. Tom Chavez presents the four steps that quality engineers should include in every test plan for apps that produce log output or other machine data. Learn the steps so your team's apps not only function but also can be monitored and understood from their machine data when running in production.